Pharmafile - Sales and Marketing News
The national shortage of HRT products could have an impact on some women, who may not be able to sleep or work efficiently due to the symptoms of...
Novo Nordisk has announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on NovoSeven® (eptacog...
Preliminary results from an ongoing nationwide health needs assessment, conducted by WHO in partnership with Premise, indicate that one in three...
Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.
A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients with glioblastoma, a rare,...
World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine alliance Gavi, to...
A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range of cancers that can...
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022. Taking place in Leipzig, Germany...
Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48...
The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 years...